Using Artificial Intelligence to Screen for Hip Dysplasia
Launched by MURDOCH CHILDRENS RESEARCH INSTITUTE · Oct 16, 2024
Trial Information
Current as of July 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring whether an ultrasound scan enhanced by artificial intelligence (AI) can accurately identify hip dysplasia in infants. Hip dysplasia is a condition where the hip joint doesn't fit properly in the hip socket. Researchers will compare the results from the AI ultrasound with standard ultrasound results to see if the AI method is just as effective. Additionally, the trial aims to gather feedback from parents about their experience with this type of screening for their children.
To participate, children need to be between 4 to 16 weeks old and scheduled for a standard hip ultrasound at The Royal Children's Hospital. If you agree to join, your child will undergo an extra ultrasound using the AI technology during their appointment. After the scan, you'll fill out a short questionnaire about your experience. This trial is currently looking for participants, and it’s important to note that children who are already receiving treatment for hip dysplasia cannot take part.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Enrolled in the VicHip study
- • Is 4-20 weeks of age at enrolment
- • Is attending The Royal Children's Hospital for the purpose of the potential diagnosis of DDH
- • Has a diagnostic (standard) hip ultrasound on the day of their out-patient appointment
- • Has a legally acceptable representative capable of understanding the informed consent document and providing consent on the participant's behalf.
- Exclusion Criteria:
- Participants will be excluded from enrolment if:
- • • They are currently receiving treatment for DDH
About Murdoch Childrens Research Institute
Murdoch Children's Research Institute (MCRI) is a leading pediatric research organization based in Australia, dedicated to improving child health through innovative research and clinical trials. With a focus on understanding and addressing the unique health challenges faced by children, MCRI collaborates with hospitals, universities, and community partners to translate research findings into practical solutions. The institute's multidisciplinary team of scientists, clinicians, and researchers is committed to advancing pediatric medicine and enhancing the quality of life for children and their families through groundbreaking studies and evidence-based interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Parkville, Victoria, Australia
Patients applied
Trial Officials
Leo T Donnan
Principal Investigator
Murdoch Childrens Research Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported